Next-Gen Nephron Sparing: The Retroperitoneoscopic Advantage for management of Renal Tumors

Introduction: Retroperitoneoscopic partial nephrectomy (RPN) is a minimally invasive surgical technique for treating localized renal tumors while preserving kidney function. Unlike the traditional transperitoneal approach, RPN accesses the kidney directly via the retroperitoneum, potentially reducing recovery time and perioperative complications. Despite a steeper learning curve, RPN is gaining acceptance as a nephron-sparing surgery option. Materials and Methods: This retrospective study analyzed 21 patients who underwent RPN between January 2020 and September 2024 for localized renal tumors ≤7 cm. Inclusion criteria included age >18, ECOG performance status 0-1, and no significant comorbidities. Patients with multiple tumors or metastatic disease were excluded. Preoperative imaging (CT or MRI) assessed tumor size, location, and complexity using the RENAL nephrometry score. Surgery involved a small incision below the 12th rib, creation of retroperitoneal space with a balloon dissector, tumor excision under renal artery clamping, and renal reconstruction with absorbable sutures. Data collected included demographics, operative time, blood loss, warm ischemia time, complications, hospital stay, surgical margins, and recurrence rates. Results: The mean patient age was 58.3 years; tumor size averaged 3.8 cm. The average operative time was 132 minutes, blood loss approximately 100 mL, warm ischemia time about 25 minutes, and hospital stay ranged around 3 days. Complications were minimal, with 14.2% incidence mostly minor. No positive surgical margins or tumor recurrence were observed during follow-up. These findings demonstrate comparable oncologic safety to traditional methods with improved perioperative outcomes. Conclusion: RPN is a safe and effective approach for managing localized renal tumors, offering nephron preservation with fewer complications, shorter operative times, and faster recovery compared to conventional approaches. Patient selection and surgical expertise are essential for optimizing outcomes. Long-term studies are needed to validate durability. With further research and improved techniques, RPN has the potential to become the preferred minimally invasive nephron-sparing surgery.